Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Heron Therapeutics (HRTX) Times Interest Earned (2016 - 2017)

Heron Therapeutics filings provide 4 years of Times Interest Earned readings, the most recent being -$492.99 for Q1 2017.

  • On a quarterly basis, Times Interest Earned fell 47.99% to -$492.99 in Q1 2017 year-over-year; TTM through Dec 2017 was -$1945.6, a 2760.63% decrease, with the full-year FY2025 number at -$0.26, up 86.17% from a year prior.
  • Times Interest Earned hit -$492.99 in Q1 2017 for Heron Therapeutics, down from -$36.85 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of -$36.85 in Q4 2016 to a low of -$492.99 in Q1 2017.
  • Median Times Interest Earned over the past 3 years was -$120.88 (2013), compared with a mean of -$174.85.
  • Biggest five-year swings in Times Interest Earned: crashed 660.75% in 2013 and later plummeted 47.99% in 2017.
  • Heron Therapeutics' Times Interest Earned stood at -$60.59 in 2013, then surged by 39.18% to -$36.85 in 2016, then tumbled by 1237.73% to -$492.99 in 2017.
  • The last three reported values for Times Interest Earned were -$492.99 (Q1 2017), -$36.85 (Q4 2016), and -$53.88 (Q3 2016) per Business Quant data.